
Quanterix Corporation QTRX
$ 2.63
-20.06%
Quarterly report 2026-Q1
added 05-06-2026
Quanterix Corporation EV/EBITDA Ratio 2011-2026 | QTRX
Annual EV/EBITDA Ratio Quanterix Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.31 | -5.68 | -20.1 | -2.23 | -14.7 | -65.4 | -17.2 | -14.1 | -15.1 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.23 | -65.4 | -17.5 |
EV/EBITDA Ratio of other stocks in the Medical devices industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Helius Medical Technologies
HSDT
|
-0.0925 | $ 2.17 | -2.25 % | $ 1.32 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-165 | $ 17.55 | 2.51 % | $ 412 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | ||
|
LENSAR
LNSR
|
-1.48 | $ 5.27 | -2.14 % | $ 63 M | ||
|
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M | ||
|
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | ||
|
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | ||
|
Orthofix Medical
OFIX
|
31.1 | $ 12.25 | 0.49 % | $ 485 M | ||
|
Alphatec Holdings
ATEC
|
-8.6 | $ 7.69 | 9.94 % | $ 1.15 B | ||
|
EDAP TMS S.A.
EDAP
|
730 | $ 4.2 | 16.83 % | $ 157 M | ||
|
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | ||
|
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | ||
|
Insulet Corporation
PODD
|
33.9 | $ 162.24 | 7.25 % | $ 11.4 B | ||
|
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-86.3 | - | -13.19 % | $ 166 K | ||
|
Sintx Technologies
SINT
|
0.974 | $ 2.44 | 1.87 % | $ 6.77 M | ||
|
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | ||
|
ClearPoint Neuro
CLPT
|
-9.73 | $ 11.68 | 1.83 % | $ 331 M | ||
|
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | ||
|
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | ||
|
Stryker Corporation
SYK
|
30 | $ 297.58 | 1.8 % | $ 114 B | ||
|
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | ||
|
Cytosorbents Corporation
CTSO
|
-4.76 | $ 0.59 | 2.63 % | $ 36.7 M | ||
|
LivaNova PLC
LIVN
|
20.1 | $ 71.08 | 7.28 % | $ 3.88 B | ||
|
Delcath Systems
DCTH
|
-1.69 | $ 11.28 | 0.18 % | $ 404 M | ||
|
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | ||
|
Tandem Diabetes Care
TNDM
|
215 | $ 18.62 | 3.27 % | $ 1.27 B | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M | ||
|
IRIDEX Corporation
IRIX
|
-11.2 | $ 1.04 | - | $ 17.6 M | ||
|
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-1.15 | - | - | $ 10.2 M | ||
|
Myomo
MYO
|
-2.96 | $ 0.87 | 1.99 % | $ 36.4 M | ||
|
Electromed
ELMD
|
26.4 | $ 26.74 | 3.06 % | $ 226 M | ||
|
Butterfly Network
BFLY
|
-3.9 | $ 4.29 | -5.82 % | $ 908 M | ||
|
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
3.87 | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
1.03 | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
27.6 | $ 88.97 | -0.29 % | $ 12 B | ||
|
CONMED Corporation
CNMD
|
40.2 | $ 37.9 | 1.55 % | $ 1.18 B | ||
|
Varex Imaging Corporation
VREX
|
18.2 | $ 12.12 | -0.41 % | $ 502 M | ||
|
Inspire Medical Systems
INSP
|
-152 | $ 46.43 | 1.6 % | $ 1.36 B | ||
|
Integer Holdings Corporation
ITGR
|
18.2 | $ 88.7 | 2.79 % | $ 3.08 B | ||
|
Invacare Corporation
IVC
|
1.89 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
34.7 | $ 83.81 | 0.73 % | $ 49 B | ||
|
Tactile Systems Technology
TCMD
|
241 | $ 26.63 | 5.26 % | $ 609 M |